Haemonetics Corp. buy BTIG Research
Start price
21.11.25
/
50%
€67.50
Target price
21.11.26
€76.29
Performance (%)
8.15%
Price
28.07.26
€73.00
Summary
This prediction is currently active. With a performance of 8.15%, the BUY prediction by BTIG_Research for Haemonetics Corp. is trending in the right direction. This prediction currently runs until 21.11.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 5.797% | 5.797% |
| iShares Core DAX® | 1,01 % | 2,70 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % |
| iShares S&P 500 | -2,72 % | -1,75 % |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€64.00
17.06.26
17.06.26
€72.34
17.06.27
17.06.27
14.06%
28.07.26
28.07.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€48.40
06.02.26
06.02.26
€74.64
06.02.27
06.02.27
50.83%
28.07.26
28.07.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.50
06.11.25
06.11.25
€76.46
06.11.26
06.11.26
26.96%
28.07.26
28.07.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
10.09.24
10.09.24
€101.52
10.09.25
10.09.25
-32.03%
11.09.25
11.09.25